IARC at the European Cancer Screening and Early Detection Policy Summit in Brussels

European Policymakers and Researchers Discuss Expanding Evidence-based Cancer Screening Programmes

European Cancer Screening and Early Detection Policy Summit

European Cancer Screening and Early Detection Policy Summit

 

Scientists from the International Agency for Research (IARC) on Cancer participated in the European Cancer Screening and Early Detection Policy Summit. It held on 17 and 18 February 2026 in Brussels and online. The event brought together policymakers, cancer researchers, clinicians and patient organizations. They discussed strategies for expanding screening and early detection programmes across Europe.

 

Translating Scientific Evidence into Policy Decisions

The summit focused on translating scientific evidence into policy decisions that can strengthen population-based screening programmes. Discussions included the potential expansion of screening initiatives for cancers such as lung, prostate and gastric cancer, as well as the implementation of updated European recommendations on cancer screening.

 

Key Theme

During the event, IARC researchers presented scientific evidence related to screening effectiveness, programme implementation and quality assurance systems. A key theme was the importance of strong data infrastructure to monitor participation rates, evaluate outcomes and ensure the quality and equity of screening programmes. Participants also examined practical challenges associated with implementing new screening initiatives, including resource allocation, workforce capacity and public engagement.

 

Organization

The summit was organized by the European Cancer Organisation and supported by the European Health and Digital Executive Agency under the EU4Health programme. The discussions highlighted the importance of collaboration between research institutions, health authorities and civil society organizations in advancing effective screening policies.

 

Screening Strategies

By bringing together scientific expertise and policy leadership, the summit contributed to ongoing European efforts to improve early detection and reduce cancer mortality through evidence-based screening strategies.

🔗 Read more

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959